Initial Results of the Phase 2 Treatment Naive Cohort in a Phase 1b/2 Study of Obinutuzumab, Ibrutinib, and Venetoclax in CLL
Miguel Risco, MD, from UC-Irvine Department of Hematology and Oncology joins us at MOASCs Spotlight On Hematology in Huntington Beach to present "Initial Results of the Phase 2 Treatment Naive Cohor...
Author: moasc
Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts
Safety of Chronic Lymphocytic Leukemia Combination Therapy - Fair Number of Hematologic & Non-Hematologic Adverse Effects
Miguel Risco, MD, from UC-Irvine Department of Hematology and Oncology joins us at MOASCs Spotlight On Hematology in Huntington Beach to talk about the safety of chronic lymphocytic leukemia combina...
Author: moasc
Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts
Toxicities with IDH1 & IDH2 Inhibitors - IDH Differentiation Syndrome is a new side-effect
Deepa Jeyakumar, MD, from UC Irvine Health For Multiple Myeloma Research joins us at MOASCs Spotlight On Hematology in Huntington Beach to discuss the toxicities with IDH1 & IDH2 inhibitors and a ne...
Author: moasc
Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts
Strategies for Treating Relapsed Myeloma - Daratumumab with IMiDs, Venetoclax, Transplants
Amrita Krishnan, MD, from The Judy and Bernard Briskin Center For Multiple Myeloma Research joins us at MOASCs Spotlight On Hematology in Huntington Beach to discuss different strategies for treatin...
Author: moasc
Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts
Trials in Combination Therapy for CLL - Phase 2 Trial results with Obinutuzumab, Ibrutunib, & Venetoclax
Miguel Risco, MD, from UC-Irvine Department of Hematology and Oncology joins us at MOASCs Spotlight On Hematology in Huntington Beach to discuss the trials in combination therapy for Chronic Lymphoc...
Author: moasc
Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts
Tandem Transplantation in Multiple Myeloma - Phase 3 Trial showed patients had a progression free survival benefit
Amrita Krishnan, MD, from The Judy and Bernard Briskin Center For Multiple Myeloma Research joins us at MOASCs Spotlight On Hematology in Huntington Beach to talk about the tandem transplantation in...
Author: moasc
Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts
Drugs to Use if One has Cancer or Clots - Rivaroxaban, Apixaban, Edoxaban are effective oral drugs
Kanwarpal Kahlon, MD, from Ronald Reagan UCLA Medical Center joins us at MOASCs Spotlight On Hematology in Huntington Beach to discuss the effective oral drugs to use (Rivaroxaban, Apixaban, Edoxaba...
Author: moasc
Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts
Bluebird Trial BCMA CAR-T on 24 Patients - Over half of patients getting complete remissions
Amrita Krishnan, MD, from The Judy and Bernard Briskin Center For Multiple Myeloma Research joins us at MOASCs Spotlight On Hematology in Huntington Beach to talk about the Bluebird trial BCMA CAR-T...
Author: moasc
Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts
Neratinib and Capecitabine for Patients with HER2+ Breast Cancer Brain Metastases (BCBM)
Daniela Bota, MD of UC Irvine Health discusses the use of neratinib and capecitabine in patients with breast cancer brain metastases at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beac...
Author: moasc
Added: 08/03/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 3, 2017 Category: Cancer & Oncology Source Type: podcasts
Nivolumab versus Nivolumab Combined with Ipilimumab in Patients with Melanoma Brain Metastases
Daniela Bota, MD of UC Irvine Health discusses the results of nivolumab versus nivolumab plus ipilimumab in patients with Melanoma at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach,...
Author: moasc
Added: 08/03/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 3, 2017 Category: Cancer & Oncology Source Type: podcasts
ARCHER 1050: Dacomitinib versus Gefitinib in EGFR+ NSCLC
Viola Zhu, MD, PhD of UC Irvine Health gives an overview of the ARCHER 1050 trial in EGFR+ non-small cell lung cancer at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA. <br /><br />Abst...
Author: moasc
Added: 08/02/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 2, 2017 Category: Cancer & Oncology Source Type: podcasts
Take-Home Message of PALOMA-1
Rita Mehta, MD of UC Irvine Health discusses the take-home message of PALOMA-1 and the impact on clinical practice at the 2017 MOASC Spotlight on Oncology in Huntington Beach, CA.<br /><br />Abstract 1001: Ov...
Author: moasc
Added: 08/02/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 2, 2017 Category: Cancer & Oncology Source Type: podcasts
Sidedness of Tumors in Metastatic Colorectal Cancer
Farshid Dayyani, MD, PhD of UC Irvine Health discusses sidedness in colorectal cancer tumors at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA.
Author: moasc
Added: 08/02/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 2, 2017 Category: Cancer & Oncology Source Type: podcasts
Overview of the IDEA Trial in Colorectal Cancer
Farshid Dayyani, MD, PhD of UC Irvine Health gives an overview of the IDEA trial at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA.
Author: moasc
Added: 08/02/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 2, 2017 Category: Cancer & Oncology Source Type: podcasts
The Immunotherapy Trials in Gastroesophageal Carcinomas
Farshid Dayyani, MD, PhD of UC Irvine Health discusses the Immunotherapy Trials, the Keynote trial and the Checkmate trial, at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA.
Author: moasc
Added: 08/02/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 2, 2017 Category: Cancer & Oncology Source Type: podcasts
